Table 3 Comparison of laboratory results before and after the treatment between groups (Group 1: Early treatment with FPV and HQ, Group 2: Late treatment with FPV and HQ, Group 3: Treatment with only HQ)
Compare groups | Mean difference | SE | p | 95% CI | |
|---|---|---|---|---|---|
CRP | Group 2–Group 3 | 37.0 | 9.9 | 0.001 | 13.3–60.6 |
Group 1–Group 2 | 13.9 | 12.5 | 0.512 | − 15.6–43.7 | |
Group 1–Group 3 | 50.9 | 10.2 | < 0.001 | 26.5–75.2 | |
Lymphocyte | Group 2–Group 3 | 16.8 | 166.3 | 0.994 | − 425.0–391.4 |
Group 2–Group 1 | 253.0 | 129.8 | 0.131 | − 56.8–562.7 | |
Group 3–Group 1 | 236.2 | 152.5 | 0.286 | − 143.7–616.1 | |
D-Dimer | Group 2–Group 3 | 0.41 | 0.72 | 0.837 | − 1.34–2.16 |
Group 2–Group 1 | 0.83 | 0.58 | 0.333 | − 0.58–2.25 | |
Group 3–Group 1 | 0.42 | 0.88 | 0.881 | − 1.68–2.53 | |
AST | Group 2–Group 3 | 20.1 | 7.3 | 0.022 | 2.42–37.7 |
Group 1–Group 2 | 2.4 | 8.2 | 0.952 | − 17.1–22.0 | |
Group 1–Group 3 | 22.5 | 5.5 | < 0.001 | 9.4–35.6 | |
ALT | Group 2–Group 3 | 10.2 | 8.3 | 0.441 | − 9.8–30.3 |
Group 1–Group 2 | 3.9 | 8.3 | 0.887 | − 16.0–23.8 | |
Group 1–Group 3 | 14.1 | 6.4 | 0.083 | − 1.5–29.8 | |
Ferritin | Group 2–Group 3 | 240.2 | 90.0 | 0.030 | 20.2–460.2 |
Group 1–Group 2 | 119.1 | 151.3 | 0.712 | − 244.7–482.8 | |
Group 1–Group 3 | 359.3 | 137.5 | 0.032 | 25.6–693.1 | |
Cr | Group 3–Group 2 | 2.39 | 1.17 | 0.138 | − 0.67–5.44 |
Group 1–Group 2 | 0.25 | 0.39 | 0.804 | − 0.69–1.18 | |
Group 3–Group 1 | 2.15 | 1.22 | 0.212 | − 0.98–5.27 |